Neighbourly Pharmacy Inc.

TSX:NBLY Stock Report

Market Cap: CA$840.4m

Neighbourly Pharmacy Future Growth

Future criteria checks 1/6

Neighbourly Pharmacy is forecast to grow revenue at 9.3% per annum.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Consumer Retailing earnings growth6.1%
Revenue growth rate9.3%
Future return on equityn/a
Analyst coverage

Low

Last updated19 Mar 2024

Recent future growth updates

Results: Neighbourly Pharmacy Inc. Delivered A Surprise Loss And Now Analysts Have New Forecasts

Feb 17
Results: Neighbourly Pharmacy Inc. Delivered A Surprise Loss And Now Analysts Have New Forecasts

Recent updates

Neighbourly Pharmacy (TSE:NBLY) Will Pay A Dividend Of CA$0.045

Aug 15
Neighbourly Pharmacy (TSE:NBLY) Will Pay A Dividend Of CA$0.045

Estimating The Fair Value Of Neighbourly Pharmacy Inc. (TSE:NBLY)

Mar 22
Estimating The Fair Value Of Neighbourly Pharmacy Inc. (TSE:NBLY)

Results: Neighbourly Pharmacy Inc. Delivered A Surprise Loss And Now Analysts Have New Forecasts

Feb 17
Results: Neighbourly Pharmacy Inc. Delivered A Surprise Loss And Now Analysts Have New Forecasts

Calculating The Fair Value Of Neighbourly Pharmacy Inc. (TSE:NBLY)

Dec 09
Calculating The Fair Value Of Neighbourly Pharmacy Inc. (TSE:NBLY)

Neighbourly Pharmacy's (TSE:NBLY) Robust Earnings Are Supported By Other Strong Factors

Aug 10
Neighbourly Pharmacy's (TSE:NBLY) Robust Earnings Are Supported By Other Strong Factors

News Flash: Analysts Just Made A Substantial Upgrade To Their Neighbourly Pharmacy Inc. (TSE:NBLY) Forecasts

Mar 21
News Flash: Analysts Just Made A Substantial Upgrade To Their Neighbourly Pharmacy Inc. (TSE:NBLY) Forecasts

Is There An Opportunity With Neighbourly Pharmacy Inc.'s (TSE:NBLY) 48% Undervaluation?

Feb 27
Is There An Opportunity With Neighbourly Pharmacy Inc.'s (TSE:NBLY) 48% Undervaluation?

Earnings and Revenue Growth Forecasts

TSX:NBLY - Analysts future estimates and past financials data (CAD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/20261,070N/A42N/A2
3/31/20251,002N/A671035
3/31/2024899N/A58933
12/30/2023875-337682N/A
9/9/2023856-377279N/A
6/17/2023832-275259N/A
3/25/2023749-154150N/A
12/31/2022671-23645N/A
9/10/202254562028N/A
6/18/202245733036N/A
3/26/2022428-73711N/A
1/1/2022398-5269N/A
9/11/2021369-1631112N/A
6/19/2021337-1631416N/A
3/27/2021306-913637N/A
1/2/2021276-1294647N/A
3/28/2020187-232728N/A
3/30/2019150-231215N/A
3/31/201893-181115N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if NBLY's forecast earnings growth is above the savings rate (2%).

Earnings vs Market: Insufficient data to determine if NBLY's earnings are forecast to grow faster than the Canadian market

High Growth Earnings: Insufficient data to determine if NBLY's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: NBLY's revenue (9.3% per year) is forecast to grow faster than the Canadian market (6.2% per year).

High Growth Revenue: NBLY's revenue (9.3% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if NBLY's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/03/20 22:05
End of Day Share Price 2024/03/20 00:00
Earnings2023/12/30
Annual Earnings2023/03/25

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Neighbourly Pharmacy Inc. is covered by 10 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Clarence PowellBMO Capital Markets Equity Research
Kyle McPheeCormark Securities Inc.
Christopher LiDesjardins Securities Inc.